Earnings Feed
Start Free
ACHIEVE LIFE SCIENCES, INC.·4

Aug 3, 8:54 PM ET

MATTINGLY MARTIN A 4

4 · ACHIEVE LIFE SCIENCES, INC. · Filed Aug 3, 2017

Insider Transaction Report

Form 4
Period: 2017-08-01
ACHIEVE LIFE SCIENCES, INC.ACHV
MATTINGLY MARTIN A
Director
Transactions
  • Award

    Stock Option (right to buy)

    2017-08-01+11,000→ 11,000 total
    Exercise: $4.57From: 2018-08-01Exp: 2027-08-01→ Common Stock (11,000 underlying)
Holdings

  • Stock Option (right to buy)

    Exercise: $156.20Exp: 2020-06-08→ Common Stock (500 underlying)
    500

  • Stock Option (right to buy)

    Exercise: $138.16Exp: 2022-05-31→ Common Stock (363 underlying)
    363

  • Stock Option (right to buy)

    Exercise: $39.82Exp: 2024-06-05→ Common Stock (454 underlying)
    454

  • Stock Option (right to buy)

    Exercise: $11.00Exp: 2026-05-26→ Common Stock (2,045 underlying)
    2,045

  • Common Stock

    954

  • Stock Option (right to buy)

    Exercise: $196.02Exp: 2021-05-26→ Common Stock (318 underlying)
    318

  • Stock Option (right to buy)

    Exercise: $118.03Exp: 2023-05-24→ Common Stock (454 underlying)
    454

  • Stock Option (right to buy)

    Exercise: $20.79Exp: 2025-05-21→ Common Stock (454 underlying)
    454
Footnotes (2)
  • [F1]Reflects the 11-for-1 reverse stock split effected on August 1, 2017 immediately following the merger between OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc.
  • [F2]The options are fully vested and exercisable.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION